Full-Time

Enterprise Business Development Representative

Posted on 9/18/2025

Ketryx

Ketryx

51-200 employees

SaaS platform for regulated medical software

Compensation Overview

$70k - $80k/yr

+ Uncapped Commission + Equity Options

No H1B Sponsorship

Boston, MA, USA

In Person

Onsite in Boston, MA; 4–5 days per week on-site.

Category
Business & Strategy (1)
Requirements
  • 2+ years in an outbound SaaS sales/Business Development Representative role (enterprise experience preferred or demonstrated track record of success)
  • Familiarity with regulated industries (e.g., MedTech, Pharma, Healthcare IT)
  • Strong writing, research, and communication skills
  • Based in Boston and available to work onsite 4–5 days/week
Responsibilities
  • Prospect and qualify enterprise medical device and diagnostics companies
  • Proactively engage inbound and outbound leads through email, LinkedIn, and phone with tailored, personalized outreach
  • Book meetings with R&D, Quality, and Regulatory leaders
  • Tailor outreach around key trends (e.g., PCCPs, AI/ML regulation, IEC 62304)
  • Collaborate closely with Account Executives and Sales Leadership on account strategy
Desired Qualifications
  • Previous experience in enterprise sales, medical device, or healthcare industry strongly preferred

Ketryx offers a SaaS Connected Lifecycle Management platform for regulated medical software. It guides the full lifecycle from planning through verification and maintenance, ensuring compliance with FDA, IEC 62304, GMP, ISO 13485, and CFR 21 Part 11. The platform integrates traceability, documentation, Jira, and SBOM management to streamline development, quality, and compliance. It targets MedTech teams from startups to large enterprises, aiming to reduce compliance risk and development costs while speeding time to market.

Company Size

51-200

Company Stage

Series B

Total Funding

$57.1M

Headquarters

Cambridge, Massachusetts

Founded

2021

Simplify Jobs

Simplify's Take

What believers are saying

  • Raised $39M Series B in September 2024 led by Transformation Capital.
  • Signed RadNet, HeartFlow, Nutrino in 2024, impacting 20M+ patients.
  • Hired Zack Jha as VP Sales, Randall Markham as Chief of Staff in 2024.

What critics are saying

  • PTC Codebeamer poaches Fortune 500 clients using Zack Jha's relationships.
  • FDA 2026 AI/ML framework invalidates Ketryx AI Agents, demands rewrites.
  • Open-source Polarion ALM diverts startups to free IEC 62304 alternatives.

What makes Ketryx unique

  • Ketryx's validated AI Agents reduce compliance work by 90% in Jira and GitHub.
  • Platform automates FDA-compliant SBOM and traceability for MedTech software.
  • Trusted by 4 of top 5 medical device manufacturers for lifecycle management.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Unlimited Paid Time Off

Stock Options

Growth & Insights and Company News

Headcount

6 month growth

7%

1 year growth

3%

2 year growth

21%
VentureFizz
Sep 30th, 2025
Hiring Unlocked: Ketryx Event Video - Company Details, Jobs, Culture, and More

Recently, Ketryx announced a $39M Series B round of funding led by Transformation Capital, with participation from existing investors including Lightspeed Venture Partners, MIT's E14 Fund, Ubiquity Ventures, and 53 Stations.

FinSMEs
Sep 4th, 2025
Ketryx Raises $39M in Series B Funding

Ketryx, a Cambridge, MA-based AI-powered compliance platform helping life sciences companies ship safer products faster, raised $39M in Series B funding

PR Newswire
Sep 4th, 2025
Ketryx Raises $39M Series B Round to Power the Future of Regulated Artificial Intelligence for Life Sciences

Ketryx raises $39M Series B round to power the future of regulated artificial intelligence for life sciences.

SiliconANGLE Media
Sep 4th, 2025
Ketryx raises $39M to help medical device makers ship safer products faster

Ketryx Corp., a company transforming product lifecycle development and compliance for medical device makers with artificial intelligence, today announced it has raised $39 million in a Series B funding round led by Transformation Capital.

TechIntelPro
May 2nd, 2025
Ketryx Launches First Validated AI Agents to Accelerate Safety-Critical Product Development

Ketryx launches first validated AI Agents to accelerate safety-critical product development.

INACTIVE